Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Following the first study conducted to investigate the prevalence of metabolic syndrome and its components in Turkey, it was aimed to demonstrate the change in general health condition of available patients after the period of time lapsed. This study will provide important information on the social and economic dimensions of metabolic syndrome and will contribute to development of preventive programs.
In the first METSAR-I study conducted in 2003, metabolic syndrome screening was made by two different team. Participants were visited at their addresses and informed about the research study and gave written consent. They were invited on an empty stomach for hospital visit on the day after. Pre-trained nurses completed the forms of patients during that second visit. After 11 years, a questionnaire by telephone survey will be applied to patients who participated in the METSAR-II study. The main goal is to determine the changes of metabolic syndrome population during that period.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Metabolic Syndrome | Other | This study will provide important information on the social and economic dimensions of metabolic syndrome |
| Measure | Description | Time Frame |
|---|---|---|
| comorbidities and changes in general health | 10 year |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
None
Not provided
Not provided
Not provided
Not provided
The previous study included 4.264 patients from 47 cities and we are going to try to get in contact all those patients. Data obtained from available patients will be analysed and the change trend will be evaluated
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Omer Kozan | Dokuz Eylul University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ankara University | Ankara | Turkey (Türkiye) | ||||
| Gazi University |
Not provided
| ID | Term |
|---|---|
| D024821 | Metabolic Syndrome |
| ID | Term |
|---|---|
| D007333 | Insulin Resistance |
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C539689 | ANAPC16 protein, human |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Ankara |
| Turkey (Türkiye) |
| Yuksek Ihtisas Hospital | Ankara | Turkey (Türkiye) |
| Istanbul Cerrahpasa University | Istanbul | Turkey (Türkiye) |
| Istanbul Medeniyet University | Istanbul | Turkey (Türkiye) |
| Prof. Dr. Omer Kozan | Izmir | Turkey (Türkiye) |
| D009750 |
| Nutritional and Metabolic Diseases |